These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9180163)

  • 1. Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
    Toffoli G; Corona G; Sorio R; Bertola A; Boiocchi M
    Int J Cancer; 1997 May; 71(5):900-6. PubMed ID: 9180163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the inhibition of azidopine binding to P-glycoprotein by MDR modulators and their efficiency in restoring doxorubicin intracellular accumulation.
    Hu YP; Chapey C; Robert J
    Cancer Lett; 1996 Dec; 109(1-2):203-9. PubMed ID: 9020922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
    Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
    Dietel M; Herzig I; Reymann A; Brandt I; Schaefer B; Bunge A; Heidebrecht HJ; Seidel A
    J Cancer Res Clin Oncol; 1994; 120(5):263-71. PubMed ID: 7907333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance.
    Toffoli G; Simone F; Corona G; Raschack M; Cappelletto B; Gigante M; Boiocchi M
    Biochem Pharmacol; 1995 Oct; 50(8):1245-55. PubMed ID: 7488241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel dithiane analogues of tiapamil with high activity to overcome multidrug resistance in vitro.
    Eliason JF; Ramuz H; Yoshikubo T; Ishikawa T; Yamamoto T; Tsuruo T
    Biochem Pharmacol; 1995 Jul; 50(2):187-96. PubMed ID: 7632162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitro.
    Germann UA; Shlyakhter D; Mason VS; Zelle RE; Duffy JP; Galullo V; Armistead DM; Saunders JO; Boger J; Harding MW
    Anticancer Drugs; 1997 Feb; 8(2):125-40. PubMed ID: 9073309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of P-glycoprotein-mediated multidrug resistance by XR9051, a novel diketopiperazine derivative.
    Dale IL; Tuffley W; Callaghan R; Holmes JA; Martin K; Luscombe M; Mistry P; Ryder H; Stewart AJ; Charlton P; Twentyman PR; Bevan P
    Br J Cancer; 1998 Oct; 78(7):885-92. PubMed ID: 9764579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole.
    Ishikawa M; Fujita R; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2000 Jan; 23(1):112-5. PubMed ID: 10706423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial circumvention of P-glycoprotein-mediated multidrug resistance by doxorubicin-14-O-hemiadipate.
    Leontieva OV; Preobrazhenskaya MN; Bernacki RJ
    Invest New Drugs; 2002 Feb; 20(1):35-48. PubMed ID: 12003193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential interaction of human renal P-glycoprotein with various metabolites and analogues of cyclosporin A.
    Charuk JH; Wong PY; Reithmeier RA
    Am J Physiol; 1995 Jul; 269(1 Pt 2):F31-9. PubMed ID: 7631829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circumvention of P-glycoprotein-mediated drug resistance in human leukaemic cells by non-immunosuppressive cyclosporin D analogue, SDZ PSC 833.
    Jiang XR; Kelsey SM; Wu YL; Newland AC
    Br J Haematol; 1995 Jun; 90(2):375-83. PubMed ID: 7794760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular levels of two cyclosporin derivatives valspodar (PSC 833) and cyclosporin a closely associated with multidrug resistance-modulating activity in sublines of human colorectal adenocarcinoma HCT-15.
    Uchiyama-Kokubu N; Watanabe T; Cohen D
    Jpn J Cancer Res; 2001 Oct; 92(10):1116-26. PubMed ID: 11676863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidrug resistance modulation in rhabdomyosarcoma and neuroblastoma cell lines.
    Cowie FJ; Pritchard-Jones K; Renshaw J; Pinkerton CR
    Int J Oncol; 1998 May; 12(5):1143-9. PubMed ID: 9538141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier.
    He L; Liu GQ
    Acta Pharmacol Sin; 2002 May; 23(5):423-9. PubMed ID: 11978192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.